发布求助
文献互助 智能选刊 最新文献

Journal of Investigational Allergology and Clinical Immunology最新文献

筛选
英文 中文
Adrenaline: A Lifeline for Rapid Drug Desensitization in Hypersensitive Patients. 肾上腺素：过敏患者快速药物脱敏的生命线。
IF 4.8 3区 医学
Journal of Investigational Allergology and Clinical Immunology Pub Date : 2026-04-14 Epub Date: 2025-04-25 DOI: 10.18176/jiaci.1075
Johana Gil-Serrano, Paula Galvan-Blasco, Javier Pereira-Gonzalez, Arnau Salvany-Pijuan, Mercedes Gonzalez Di-Paolo, Mar Guilarte, Olga Luengo, Anna Sala-Cunill, Victoria Cardona, Moisés Labrador-Horrillo
{"title":"Adrenaline: A Lifeline for Rapid Drug Desensitization in Hypersensitive Patients.","authors":"Johana Gil-Serrano, Paula Galvan-Blasco, Javier Pereira-Gonzalez, Arnau Salvany-Pijuan, Mercedes Gonzalez Di-Paolo, Mar Guilarte, Olga Luengo, Anna Sala-Cunill, Victoria Cardona, Moisés Labrador-Horrillo","doi":"10.18176/jiaci.1075","DOIUrl":"10.18176/jiaci.1075","url":null,"abstract":"<p><strong>Background and objective: </strong>Chemotherapeutic agents (CMTs) and monoclonal antibodies (mAbs) are common causes of drug allergy, which is often managed using rapid drug desensitization (RDD). Despite its effectiveness, RDD can be hampered by severe breakthrough reactions (BTRs), potentially leading to failure of the procedure. Objective: To evaluate the usefulness and safety of adrenaline infusion (AI) as an adjuvant during RDD in patients who experience severe drug hypersensitivity reaction (DHR) during standard desensitization protocols.</p><p><strong>Methods: </strong>Retrospective observational study, analyzing data from patients who underwent RDD to CMTs or mAbs in a tertiary hospital from January 2015 to June 2024. We included patients who required AI to safely achieve RDD after a severe initial DHR or failure of a standard RDD protocol due to repeated DHRs. Comorbidities, adrenaline doses, and adverse events (AEs) were assessed.</p><p><strong>Results: </strong>RDD with AI was administered in 42 patients. Of these, 77% (n=32) were women, and the mean age was 57 years. The most frequently involved drugs were platinum salts (58%), mAbs (26%), and taxanes (14%). A total of 151 RDDs were performed with AI. Skin tests were positive in 69% of patients. The most frequent initial BTR (65%) was moderate or severe anaphylaxis. The most common AEs induced by AI were tremor (14%) and tachycardia (7%), which resolved after reducing the AI infusion rate. The median (IQR) cumulative dose of adrenaline administered throughout the RDD procedure was 0.76 mg (0.4-1.2mg), with a median infusion rate of 8 mL/h (4- 15ml/h), and median maximum AI rate of 3.33 μg/min (2-5.3 μg/min).</p><p><strong>Conclusions: </strong>AI is a useful and safe therapeutic tool for selected high-risk desensitization procedures, mitigating severe DHR with mostly minor AEs.</p>","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"113-120"},"PeriodicalIF":4.8,"publicationDate":"2026-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144058741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Position Statement on Autonomous Adrenaline Administration for Anaphylaxis by Nursing Professionals in Spain: Joint Recommendations From the Anaphylaxis and Nursing Committees of the Spanish Society of Allergy and Clinical Immunology (SEAIC). 西班牙护理专业人员对过敏反应自主肾上腺素管理的立场声明：西班牙过敏和临床免疫学学会（SEAIC）过敏反应和护理委员会的联合建议。
IF 4.8 3区 医学
Journal of Investigational Allergology and Clinical Immunology Pub Date : 2026-04-14 Epub Date: 2025-12-15 DOI: 10.18176/jiaci.1138
Gustavo-Jorge Molina-Molina, Dolores López, Filip Skrabski, Valentín López-Carrasco, Pilar Hernández, Victoria Cardona
{"title":"Position Statement on Autonomous Adrenaline Administration for Anaphylaxis by Nursing Professionals in Spain: Joint Recommendations From the Anaphylaxis and Nursing Committees of the Spanish Society of Allergy and Clinical Immunology (SEAIC).","authors":"Gustavo-Jorge Molina-Molina, Dolores López, Filip Skrabski, Valentín López-Carrasco, Pilar Hernández, Victoria Cardona","doi":"10.18176/jiaci.1138","DOIUrl":"10.18176/jiaci.1138","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"167-169"},"PeriodicalIF":4.8,"publicationDate":"2026-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dupilumab in Eosinophilic Gastrointestinal Disorders With Extraesophageal Involvement: A Pediatric Case Series and Systematic Review. Dupilumab治疗食管外受累的嗜酸性胃肠道疾病：儿科病例系列和系统回顾。
IF 4.8 3区 医学
Journal of Investigational Allergology and Clinical Immunology Pub Date : 2026-04-14 Epub Date: 2025-11-05 DOI: 10.18176/jiaci.1098
Camille Braun, Kelly Grzywacz, Dorothée Dal Soglio, Eric Drouin, Marie E Chartier, Martha Dirks, Laurence Chapuy, Kathryn Samaan, François Graham, Louis Paradis, Anne Des Roches, Philippe Bégin
{"title":"Dupilumab in Eosinophilic Gastrointestinal Disorders With Extraesophageal Involvement: A Pediatric Case Series and Systematic Review.","authors":"Camille Braun, Kelly Grzywacz, Dorothée Dal Soglio, Eric Drouin, Marie E Chartier, Martha Dirks, Laurence Chapuy, Kathryn Samaan, François Graham, Louis Paradis, Anne Des Roches, Philippe Bégin","doi":"10.18176/jiaci.1098","DOIUrl":"10.18176/jiaci.1098","url":null,"abstract":"<p><p>Dupilumab has proven effective in the treatment of eosinophilic esophagitis (EoE) in randomized controlled trials. Its efficacy in other, less common and generally more severe eosinophilic gastrointestinal disorders (EGIDs) is scientifically plausible, although it has not been studied to date. Our objective was to describe published and our experience on the empirical use of dupilumab in patients affected by EGIDs with extraesophageal involvement. We retrospectively analyzed the medical charts of children diagnosed with extraesophageal EGIDs treated with dupilumab at our tertiary medical center. The Medline, Embase, and Cochrane databases were searched up to January 2025 for articles describing the use of dupilumab in patients with diagnosed or suspected extraesophageal EGID. Our cohort included 8 patients with a clinical and histological diagnosis of EGID and extraesophageal involvement. All of them had recurrent gastrointestinal symptoms refractory to standard treatments. Three patients had growth retardation. In all patients, symptoms and macroscopic and histological abnormalities, including eosinophilic infiltration, quickly improved after initiation of dupilumab. The systematic review identified 11 case reports (n=29 patients) of pediatric and adult patients with extraesophageal EGIDs treated with dupilumab. All 11 reports described significant clinical and histological improvement following therapy. Clinical experience suggests that dupilumab is effective in treating pediatric EGIDs with extraesophageal features. Given the rarity and high morbidity of these disorders, dupilumab could be considered a reasonable option while waiting for high-quality evidence from ongoing randomized controlled trials.</p>","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"100-112"},"PeriodicalIF":4.8,"publicationDate":"2026-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145460454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Allergenic Relevance of Vespula alascensis Venom: Implications for Venom Immunotherapy. 评估黄脉蛇毒液的致敏性：对毒液免疫治疗的影响。
IF 4.8 3区 医学
Journal of Investigational Allergology and Clinical Immunology Pub Date : 2026-04-14 Epub Date: 2025-11-21 DOI: 10.18176/jiaci.1108
Benjamin O Slusarenko, Klara F Borrmann, Claudia Knappe, Jonathan Vogel, Benjamin Schnautz, Stéphanie Kler, Tilo Biedermann, Knut Brockow, Ulf Darsow, Thalia Carreno Velazquez, Elisabetta Francescato, Simon J Hewings, Matthias F Kramer, Matthew D Heath, Gunnar Dittmar, Christiane Hilger, Ralph S Peters, Carsten B Schmidt-Weber, Bernadette Eberlein, Simon Blank
{"title":"Assessing the Allergenic Relevance of Vespula alascensis Venom: Implications for Venom Immunotherapy.","authors":"Benjamin O Slusarenko, Klara F Borrmann, Claudia Knappe, Jonathan Vogel, Benjamin Schnautz, Stéphanie Kler, Tilo Biedermann, Knut Brockow, Ulf Darsow, Thalia Carreno Velazquez, Elisabetta Francescato, Simon J Hewings, Matthias F Kramer, Matthew D Heath, Gunnar Dittmar, Christiane Hilger, Ralph S Peters, Carsten B Schmidt-Weber, Bernadette Eberlein, Simon Blank","doi":"10.18176/jiaci.1108","DOIUrl":"10.18176/jiaci.1108","url":null,"abstract":"<p><strong>Background and objective: </strong>Venom immunotherapy (VIT) is an effective treatment for yellow jacket venom (YJV) allergy. It is often based on mixtures of venom from different species. Recent taxonomic re-evaluation has revealed that widely used VIT preparations contain venom from Vespula alascensis, a North American species, rather than venom from the Palearctic Vespula vulgaris. Objective: To assess the allergenic relevance of V alascensis venom for European patients and evaluate its suitability for inclusion in VIT preparations.</p><p><strong>Methods: </strong>The ability of V alascensis and V vulgaris venom to activate effector cells from YJV-allergic patients from Germany was compared using the basophil activation test. Patients' sIgE reactivity was assessed using ELISA, inhibition ELISA, CAP inhibition, and Western blot. Proteomic analysis of the venoms was also conducted.</p><p><strong>Results: </strong>Basophil activation tests showed highly similar activation profiles for V alascensis and V vulgaris venoms. Moreover, ELISA and inhibition analyses revealed comparable overall sIgE reactivity for both venoms. In contrast, Western blot analysis demonstrated similar sIgE profiles for antigen 5 allergens, although phospholipase A1 allergens were differentially detected. Proteomic analysis revealed no differences in the major allergens of the 2 venoms.</p><p><strong>Conclusion: </strong>This study demonstrates the functional similarity between V alascensis and V vulgaris venoms in allergic responses. Moreover, it highlights the clinical relevance of V alascensis for YJV-sensitized European patients and supports its inclusion in YJV VIT preparations in Europe.</p>","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"121-131"},"PeriodicalIF":4.8,"publicationDate":"2026-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145589826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of Specific Venom Immunotherapy to Vespa velutina nigrithorax Through Controlled Re-sting With Asian Hornet. 亚洲大黄蜂控制针刺特异性毒液免疫治疗羽绒小黄蜂黑胸的疗效验证。
IF 4.8 3区 医学
Journal of Investigational Allergology and Clinical Immunology Pub Date : 2026-04-14 Epub Date: 2025-12-19 DOI: 10.18176/jiaci.1134
Cristina Galán Gimeno, Ángel Arrien de Lecea, Javier Sánchez de Vicente, Mónica Pérez Escalera, Aritza Segurola Azcarate, Ignacio Jáuregui Presa
{"title":"Validation of Specific Venom Immunotherapy to Vespa velutina nigrithorax Through Controlled Re-sting With Asian Hornet.","authors":"Cristina Galán Gimeno, Ángel Arrien de Lecea, Javier Sánchez de Vicente, Mónica Pérez Escalera, Aritza Segurola Azcarate, Ignacio Jáuregui Presa","doi":"10.18176/jiaci.1134","DOIUrl":"10.18176/jiaci.1134","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"155-157"},"PeriodicalIF":4.8,"publicationDate":"2026-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metal Hypersensitivity-Related Refractory Coronary In-Stent Restenosis Treated With Prednisone and Dupilumab: A Case Report. 强的松联合杜匹单抗治疗金属超敏性冠脉支架内再狭窄1例
IF 4.8 3区 医学
Journal of Investigational Allergology and Clinical Immunology Pub Date : 2026-04-14 Epub Date: 2025-12-09 DOI: 10.18176/jiaci.1131
Yiyun Pang, Qian Wang, Lei Jia, Rui Tang
{"title":"Metal Hypersensitivity-Related Refractory Coronary In-Stent Restenosis Treated With Prednisone and Dupilumab: A Case Report.","authors":"Yiyun Pang, Qian Wang, Lei Jia, Rui Tang","doi":"10.18176/jiaci.1131","DOIUrl":"10.18176/jiaci.1131","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"153-155"},"PeriodicalIF":4.8,"publicationDate":"2026-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145710149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking Penicillin Allergy Pathways: Insights from a 5-Year Audit at Barts Health NHS Trust. 重新思考青霉素过敏途径：从巴茨健康NHS信托5年审计的见解。
IF 4.8 3区 医学
Journal of Investigational Allergology and Clinical Immunology Pub Date : 2026-04-14 Epub Date: 2025-12-16 DOI: 10.18176/jiaci.1127
Maria L Quiñones Obando, Rodanthe Nixon, Anand Sundaralingam, Bryan N Fernandes, Fawzia R Ali, Ricardo Madrigal-Burgaleta
{"title":"Rethinking Penicillin Allergy Pathways: Insights from a 5-Year Audit at Barts Health NHS Trust.","authors":"Maria L Quiñones Obando, Rodanthe Nixon, Anand Sundaralingam, Bryan N Fernandes, Fawzia R Ali, Ricardo Madrigal-Burgaleta","doi":"10.18176/jiaci.1127","DOIUrl":"10.18176/jiaci.1127","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"150-152"},"PeriodicalIF":4.8,"publicationDate":"2026-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acquired Hemophilia A Following Omalizumab Treatment in a Patient With Chronic Spontaneous Urticaria. 慢性自发性荨麻疹患者接受Omalizumab治疗后获得性血友病A
IF 4.8 3区 医学
Journal of Investigational Allergology and Clinical Immunology Pub Date : 2026-04-14 Epub Date: 2025-12-09 DOI: 10.18176/jiaci.1144
M Teresa Dordal-Culla, Blanca Andrés-López, Dario Alexandre Duminy, Gemma Rocamora Blanch, Laura López-Andreoni, M Dolores Rodríguez-Cumplido, Ramon Lleonart Bellfill
{"title":"Acquired Hemophilia A Following Omalizumab Treatment in a Patient With Chronic Spontaneous Urticaria.","authors":"M Teresa Dordal-Culla, Blanca Andrés-López, Dario Alexandre Duminy, Gemma Rocamora Blanch, Laura López-Andreoni, M Dolores Rodríguez-Cumplido, Ramon Lleonart Bellfill","doi":"10.18176/jiaci.1144","DOIUrl":"10.18176/jiaci.1144","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"162-164"},"PeriodicalIF":4.8,"publicationDate":"2026-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145710072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delayed Anaphylaxis to Multiple Antihistamines and the Use of Basophil Activation Testing for Diagnosis. 延迟过敏反应对多种抗组胺药和使用嗜碱性粒细胞激活试验诊断。
IF 4.8 3区 医学
Journal of Investigational Allergology and Clinical Immunology Pub Date : 2026-04-14 Epub Date: 2026-02-09 DOI: 10.18176/jiaci.1137
Monica C Patterson, Emily M Mulcahy, Troy Wanandy, Wun Y Lau, Thanh-Thao A Le
{"title":"Delayed Anaphylaxis to Multiple Antihistamines and the Use of Basophil Activation Testing for Diagnosis.","authors":"Monica C Patterson, Emily M Mulcahy, Troy Wanandy, Wun Y Lau, Thanh-Thao A Le","doi":"10.18176/jiaci.1137","DOIUrl":"10.18176/jiaci.1137","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"157-159"},"PeriodicalIF":4.8,"publicationDate":"2026-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146144522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Future Perspectives for Artificial Intelligence in Allergy: Advances in Diagnosis, Monitoring, and Personalized Care. 过敏人工智能的未来展望：诊断、监测和个性化护理的进展。
IF 4.8 3区 医学
Journal of Investigational Allergology and Clinical Immunology Pub Date : 2026-04-14 Epub Date: 2026-03-10 DOI: 10.18176/jiaci.1154
Esther Moreno, Vidal Moreno, Belén Curto, Ignacio Dávila
{"title":"Future Perspectives for Artificial Intelligence in Allergy: Advances in Diagnosis, Monitoring, and Personalized Care.","authors":"Esther Moreno, Vidal Moreno, Belén Curto, Ignacio Dávila","doi":"10.18176/jiaci.1154","DOIUrl":"10.18176/jiaci.1154","url":null,"abstract":"<p><p>Artificial intelligence (AI) is significantly transforming the specialty of allergy by offering novel tools for diagnosis, risk prediction, disease monitoring, and personalized care. This narrative review comprehensively explores key advances in the application of AI techniques-expert systems, machine learning, deep learning, and natural language processing-across various allergic diseases such as asthma, anaphylaxis, atopic dermatitis, food allergy, allergic rhinitis, eosinophilic esophagitis, and drug hypersensitivity reactions. Despite these advancements, several challenges persist, including model interpretability, external validation, and ethical and regulatory barriers. Nonetheless, AI holds strong potential to enhance diagnostic efficiency, therapeutic precision, and patient outcomes. This review presents an updated perspective on the state of the art of AI in allergy, highlighting both its achievements and ongoing challenges.</p>","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"85-99"},"PeriodicalIF":4.8,"publicationDate":"2026-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147437084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书